LUMIQUIN cream contains Hydroquinone, as a depigmenting agent, and may interrupt one or more steps in the tyrosine-tyrosinase pathway of melanin synthesis, Tretinoin as a keratolytic agent, and Fluocinolone acetonide as an anti-inflammatory agent. However, the mechanism of action of the active ingredients in LUMIQUIN cream in the treatment of melasma is unknown.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
